Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3688 Novel von Hippel-Lindau-related pancreatic neuroendocrine neoplasms in-vivo model

Introduction: Von Hippel-Lindau (VHL) disease is a familial cancer syndrome caused by a germline mutation in the VHL tumor suppressor gene. Although VHL-related pancreatic neuroendocrine neoplasms (vPNEN) have been reported, their molecular pathogenesis is not fully investigated.

Conference:

Presenting Author:

Authors: Telerman A, Yossef Y, Chmelnik A, Tirosh A,

Keywords: VHL, PNEN, BON1, pseudohypoxia, CDX,

#3668 Factors contributing to tumor shrinkage after peptide receptor radionuclide therapy in patients with unresectable neuroendocrine tumors

Introduction: Peptide receptor activation therapy (PRRT) is a promising treatment option for metastatic neuroendocrine tumors (NETs). However, predicting tumor shrinkage before treatment is challenging.

Conference:

Presenting Author:

Authors: Noritoshi K, Sho H, Wild D, Kaul F, Motokazu S,

Keywords: lesion-based analysis, neuroendocrine tumor, peptide receptor radionuclide therapy,

#3302 Analysis of clinicopathological characteristics and prognosis 232 cases of gastric neuroendocrine carcinoma

Introduction: Neuroendocrine neoplasms (NEN) are a group of heterogeneous and rare malignant tumors originating from peptidergic neurons and neuroendocrine cells. According to the US SEER data report, the incidence of NENs increased from 1.09 per 100,000 in 1973 to 6.98 per 100,000 in 2012, especially gastric neuroendocrine tumors (G-NEN) have increased 15-fold in recent decades and reached 4.85/1,000,000 in 2014.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Han D

Authors: Han D, Li Y, Chen Y, Tan H,

Keywords: gastric neuroendocrine carcinoma, clinicopathological characteristics, treatment, prognosis, statistical analysis, tumor diameter,

#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters

Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Monteleone M, Rossi R, Altomare M, Prinzi N, Cattaneo L,

Keywords: Pancreatic neuroendocrine neoplasia, Liver metastases,

#1479 Comparison of Radiological and Histological Tumor Size in Pancreatic Neuroendocrine Neoplasm

Introduction: Radiological tumor size of pancreatic neuroendocrine neoplasms (PNEN) is crucial for management especially for asymptomatic, small lesions.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Polenta V

Authors: Polenta V, Partelli S, Wiese D, Fendrich V, Muffatti F,

Keywords: Pancreatic neuroendocrine neoplasm, size, radiology, pathology, surgery,